Finding an antidote for China’s pharmaceutical scandal is proving elusive. Earlier this week, two more Chinese drugmakers recalled blood-pressure products, which had been exported to Taiwan, because of a potential impurity linked to cancer. The decision comes less than a month after Zhejiang Huahai Pharmaceutical triggered a global alert over a similar issue. Batches of […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.